Global Small Nucleic Acid-Based Drug Market Growth (Status and Outlook) 2025-2031

Publication ID:

LPI03258785

Publication Date:

March 5, 2025

Pages:

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

The global Small Nucleic Acid-Based Drug market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.
United States market for Small Nucleic Acid-Based Drug is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for Small Nucleic Acid-Based Drug is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for Small Nucleic Acid-Based Drug is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key Small Nucleic Acid-Based Drug players cover Biogen, Pfizer, Jazz, Sarepta Therapeutics, Alnylam, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
The 鈥淪mall Nucleic Acid-Based Drug Industry Forecast鈥� looks at past sales and reviews total world Small Nucleic Acid-Based Drug sales in 2024, providing a comprehensive analysis by region and market sector of projected Small Nucleic Acid-Based Drug sales for 2025 through 2031. With Small Nucleic Acid-Based Drug sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Small Nucleic Acid-Based Drug industry.
This Insight Report provides a comprehensive analysis of the global Small Nucleic Acid-Based Drug landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Small Nucleic Acid-Based Drug portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global Small Nucleic Acid-Based Drug market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Small Nucleic Acid-Based Drug and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Small Nucleic Acid-Based Drug.
This report presents a comprehensive overview, market shares, and growth opportunities of Small Nucleic Acid-Based Drug market by product type, application, key players and key regions and countries.
Segmentation by Type:
siRNA
Antisense Oligonucleotides
Segmentation by Application:
Hospital
Specialty Clinic
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Biogen
Pfizer
Jazz
Sarepta Therapeutics
Alnylam
Novartis
Nippon Shinyaku
Swedish Orphan Biovitrum

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Small Nucleic Acid-Based Drug Market Size (2020-2031)
2.1.2 Small Nucleic Acid-Based Drug Market Size CAGR by Region (2020 VS 2024 VS 2031)
2.1.3 World Current & Future Analysis for Small Nucleic Acid-Based Drug by Country/Region (2020, 2024 & 2031)
2.2 Small Nucleic Acid-Based Drug Segment by Type
2.2.1 siRNA
2.2.2 Antisense Oligonucleotides
2.3 Small Nucleic Acid-Based Drug Market Size by Type
2.3.1 Small Nucleic Acid-Based Drug Market Size CAGR by Type (2020 VS 2024 VS 2031)
2.3.2 Global Small Nucleic Acid-Based Drug Market Size Market Share by Type (2020-2025)
2.4 Small Nucleic Acid-Based Drug Segment by Application
2.4.1 Hospital
2.4.2 Specialty Clinic
2.4.3 Others
2.5 Small Nucleic Acid-Based Drug Market Size by Application
2.5.1 Small Nucleic Acid-Based Drug Market Size CAGR by Application (2020 VS 2024 VS 2031)
2.5.2 Global Small Nucleic Acid-Based Drug Market Size Market Share by Application (2020-2025)
3 Small Nucleic Acid-Based Drug Market Size by Player
3.1 Small Nucleic Acid-Based Drug Market Size Market Share by Player
3.1.1 Global Small Nucleic Acid-Based Drug Revenue by Player (2020-2025)
3.1.2 Global Small Nucleic Acid-Based Drug Revenue Market Share by Player (2020-2025)
3.2 Global Small Nucleic Acid-Based Drug Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Small Nucleic Acid-Based Drug by Region
4.1 Small Nucleic Acid-Based Drug Market Size by Region (2020-2025)
4.2 Global Small Nucleic Acid-Based Drug Annual Revenue by Country/Region (2020-2025)
4.3 Americas Small Nucleic Acid-Based Drug Market Size Growth (2020-2025)
4.4 APAC Small Nucleic Acid-Based Drug Market Size Growth (2020-2025)
4.5 Europe Small Nucleic Acid-Based Drug Market Size Growth (2020-2025)
4.6 Middle East & Africa Small Nucleic Acid-Based Drug Market Size Growth (2020-2025)
5 Americas
5.1 Americas Small Nucleic Acid-Based Drug Market Size by Country (2020-2025)
5.2 Americas Small Nucleic Acid-Based Drug Market Size by Type (2020-2025)
5.3 Americas Small Nucleic Acid-Based Drug Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Small Nucleic Acid-Based Drug Market Size by Region (2020-2025)
6.2 APAC Small Nucleic Acid-Based Drug Market Size by Type (2020-2025)
6.3 APAC Small Nucleic Acid-Based Drug Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Small Nucleic Acid-Based Drug Market Size by Country (2020-2025)
7.2 Europe Small Nucleic Acid-Based Drug Market Size by Type (2020-2025)
7.3 Europe Small Nucleic Acid-Based Drug Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Small Nucleic Acid-Based Drug by Region (2020-2025)
8.2 Middle East & Africa Small Nucleic Acid-Based Drug Market Size by Type (2020-2025)
8.3 Middle East & Africa Small Nucleic Acid-Based Drug Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Small Nucleic Acid-Based Drug Market Forecast
10.1 Global Small Nucleic Acid-Based Drug Forecast by Region (2026-2031)
10.1.1 Global Small Nucleic Acid-Based Drug Forecast by Region (2026-2031)
10.1.2 Americas Small Nucleic Acid-Based Drug Forecast
10.1.3 APAC Small Nucleic Acid-Based Drug Forecast
10.1.4 Europe Small Nucleic Acid-Based Drug Forecast
10.1.5 Middle East & Africa Small Nucleic Acid-Based Drug Forecast
10.2 Americas Small Nucleic Acid-Based Drug Forecast by Country (2026-2031)
10.2.1 United States Market Small Nucleic Acid-Based Drug Forecast
10.2.2 Canada Market Small Nucleic Acid-Based Drug Forecast
10.2.3 Mexico Market Small Nucleic Acid-Based Drug Forecast
10.2.4 Brazil Market Small Nucleic Acid-Based Drug Forecast
10.3 APAC Small Nucleic Acid-Based Drug Forecast by Region (2026-2031)
10.3.1 China Small Nucleic Acid-Based Drug Market Forecast
10.3.2 Japan Market Small Nucleic Acid-Based Drug Forecast
10.3.3 Korea Market Small Nucleic Acid-Based Drug Forecast
10.3.4 Southeast Asia Market Small Nucleic Acid-Based Drug Forecast
10.3.5 India Market Small Nucleic Acid-Based Drug Forecast
10.3.6 Australia Market Small Nucleic Acid-Based Drug Forecast
10.4 Europe Small Nucleic Acid-Based Drug Forecast by Country (2026-2031)
10.4.1 Germany Market Small Nucleic Acid-Based Drug Forecast
10.4.2 France Market Small Nucleic Acid-Based Drug Forecast
10.4.3 UK Market Small Nucleic Acid-Based Drug Forecast
10.4.4 Italy Market Small Nucleic Acid-Based Drug Forecast
10.4.5 Russia Market Small Nucleic Acid-Based Drug Forecast
10.5 Middle East & Africa Small Nucleic Acid-Based Drug Forecast by Region (2026-2031)
10.5.1 Egypt Market Small Nucleic Acid-Based Drug Forecast
10.5.2 South Africa Market Small Nucleic Acid-Based Drug Forecast
10.5.3 Israel Market Small Nucleic Acid-Based Drug Forecast
10.5.4 Turkey Market Small Nucleic Acid-Based Drug Forecast
10.6 Global Small Nucleic Acid-Based Drug Forecast by Type (2026-2031)
10.7 Global Small Nucleic Acid-Based Drug Forecast by Application (2026-2031)
10.7.1 GCC Countries Market Small Nucleic Acid-Based Drug Forecast
11 Key Players Analysis
11.1 Biogen
11.1.1 Biogen Company Information
11.1.2 Biogen Small Nucleic Acid-Based Drug Product Offered
11.1.3 Biogen Small Nucleic Acid-Based Drug Revenue, Gross Margin and Market Share (2020-2025)
11.1.4 Biogen Main Business Overview
11.1.5 Biogen Latest Developments
11.2 Pfizer
11.2.1 Pfizer Company Information
11.2.2 Pfizer Small Nucleic Acid-Based Drug Product Offered
11.2.3 Pfizer Small Nucleic Acid-Based Drug Revenue, Gross Margin and Market Share (2020-2025)
11.2.4 Pfizer Main Business Overview
11.2.5 Pfizer Latest Developments
11.3 Jazz
11.3.1 Jazz Company Information
11.3.2 Jazz Small Nucleic Acid-Based Drug Product Offered
11.3.3 Jazz Small Nucleic Acid-Based Drug Revenue, Gross Margin and Market Share (2020-2025)
11.3.4 Jazz Main Business Overview
11.3.5 Jazz Latest Developments
11.4 Sarepta Therapeutics
11.4.1 Sarepta Therapeutics Company Information
11.4.2 Sarepta Therapeutics Small Nucleic Acid-Based Drug Product Offered
11.4.3 Sarepta Therapeutics Small Nucleic Acid-Based Drug Revenue, Gross Margin and Market Share (2020-2025)
11.4.4 Sarepta Therapeutics Main Business Overview
11.4.5 Sarepta Therapeutics Latest Developments
11.5 Alnylam
11.5.1 Alnylam Company Information
11.5.2 Alnylam Small Nucleic Acid-Based Drug Product Offered
11.5.3 Alnylam Small Nucleic Acid-Based Drug Revenue, Gross Margin and Market Share (2020-2025)
11.5.4 Alnylam Main Business Overview
11.5.5 Alnylam Latest Developments
11.6 Novartis
11.6.1 Novartis Company Information
11.6.2 Novartis Small Nucleic Acid-Based Drug Product Offered
11.6.3 Novartis Small Nucleic Acid-Based Drug Revenue, Gross Margin and Market Share (2020-2025)
11.6.4 Novartis Main Business Overview
11.6.5 Novartis Latest Developments
11.7 Nippon Shinyaku
11.7.1 Nippon Shinyaku Company Information
11.7.2 Nippon Shinyaku Small Nucleic Acid-Based Drug Product Offered
11.7.3 Nippon Shinyaku Small Nucleic Acid-Based Drug Revenue, Gross Margin and Market Share (2020-2025)
11.7.4 Nippon Shinyaku Main Business Overview
11.7.5 Nippon Shinyaku Latest Developments
11.8 Swedish Orphan Biovitrum
11.8.1 Swedish Orphan Biovitrum Company Information
11.8.2 Swedish Orphan Biovitrum Small Nucleic Acid-Based Drug Product Offered
11.8.3 Swedish Orphan Biovitrum Small Nucleic Acid-Based Drug Revenue, Gross Margin and Market Share (2020-2025)
11.8.4 Swedish Orphan Biovitrum Main Business Overview
11.8.5 Swedish Orphan Biovitrum Latest Developments
12 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂